NextPoint Therapeutics
Cambridge, MA
NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.
nextpointtx.comCompany Details
Founded
- 2020
Employees
- Between 50 - 100 employees
Raised
- $122,500,000
Headquarters Location
- Cambridge, MA
Public
- No
Acquired
- No
CEO
Ivan Cheung
Founders
- Gordon FreemanXingxing Zang
Company Collections
These are collections NextPoint Therapeutics is a part of. Click on the collection name to view similar companies.